Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,574 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients.
Leal CTS, Costa LJM, Pereira J, Duarte FB, Tavares RB, Atalla A, Sabioni BS, Neto AEH. Leal CTS, et al. Among authors: costa ljm. Bone Marrow Transplant. 2021 Nov 29. doi: 10.1038/s41409-021-01531-3. Online ahead of print. Bone Marrow Transplant. 2021. PMID: 34845366 No abstract available.
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma.
Costa LJ, Lin Y, Cornell RF, Martin T, Chhabra S, Usmani SZ, Jagannath S, Callander NS, Berdeja JG, Kang Y, Vij R, Godby KN, Malek E, Neppalli A, Liedtke M, Fiala M, Tian H, Valluri S, Marino J, Jackson CC, Banerjee A, Kansagra A, Schecter JM, Kumar S, Hari P. Costa LJ, et al. Clin Lymphoma Myeloma Leuk. 2021 Oct 30:S2152-2650(21)02416-2. doi: 10.1016/j.clml.2021.10.013. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34840088
3,574 results